AMPD1: A novel therapeutic target for reversing insulin resistance
10.1186/1472-6823-14-96
Saved in:
Main Authors: | Cheng J., Morisaki H., Toyama K., Sugimoto N., Shintani T., Tandelilin A., Hirase T., Holmes E.W., Morisaki T. |
---|---|
Other Authors: | DEPT OF MEDICINE |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143224 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
NHE-1: A promising target for novel anti-cancer therapeutics
by: Loo, S.Y., et al.
Published: (2014) -
Reversal of insulin lipoatrophy by monocomponent insulin
by: Aw, T.C., et al.
Published: (2014) -
Reversal of insulin lipoatrophy by monocomponent insulin
by: Aw, T.C., et al.
Published: (2016) -
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
by: Wee, Z.N, et al.
Published: (2020) -
Heat shock proteins as novel therapeutic targets in cancer
by: Soo, E.T.L., et al.
Published: (2011)